Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera <sup>®</sup> ) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial
Yuankai Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanan Ji(Nantong University), Xiaoyan Ke, Liangming Zhang(Sun Yat-sen University), Liqun Zou(Sichuan University), Lida Shen(Sun Yat-sen University), Chuan Jin(Guangzhou Medical University), Yajie Gao(Dalian Medical University), Hong Cen(Guangxi Medical University), Zhendong Zheng(General Hospital of Shenyang Military Region), Liangzhi Xie(Sinocelltech Group (China)), Haiyan Yang(Zhejiang Cancer Hospital), Miaowang Hao(Tang Du Hospital), Chengyun Zheng(Second Hospital of Shandong University), Chunkang Chang(Shanghai Jiao Tong University), Yunhong Huang(Guiyang Medical University), Lin Gui(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianda Hu(Fujian Medical University), Wenlin Gai(Sinocelltech Group (China)), Shaoshui Chen(Binzhou Medical University), Mingzhi Zhang(Chinese Academy of Sciences), Xiaoling Li(Southwest University), Zhen Wang(Huanghuai University), Zhao Wang(Capital Medical University), Linhua Yang(Shanxi Medical University), Liling Zhang(Union Hospital), Jifeng Feng(Jiangsu Cancer Hospital), Qingyuan Zhang(Third Affiliated Hospital of Harbin Medical University), Weihua Zhang(Zhejiang A & F University), Yun Tang(Sichuan University), Yaming Xi(First Hospital of Lanzhou University), Yuhuan Gao(Hebei Medical University), Hui Wu(Fuzhou University), Xiaonan Hong(Shanghai Medical College of Fudan University), Yufu Li(Henan Cancer Hospital)
Cited by 9
Related Papers
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
|The Lancet Oncology|2016|1.2k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Symmetrical MnO<sub>2</sub>–Carbon Nanotube–Textile Nanostructures for Wearable Pseudocapacitors with High Mass Loading
|ACS Nano|2011|625
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
|Molecular Cancer|2020|578
Aspect-based sentiment analysis via affective knowledge enhanced graph convolutional networks
|Knowledge-Based Systems|2021|518